Ana Isabel Torres‐Suárez

Author

Also Known As

A I Torres, A I Torres Suárez, A I Torres-Suarez, A I Torres-Suárez, A Torres, A. I. Torres, A. I. Torres-Suárez, A. Suarez, A. Torres-Suárez, A.I Torres-Suarez

137

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Universidad Complutense de Madrid Universidad de Alcalá Universidad de Granada University of Geneva Centre National de la Recherche Scientifique

About

Ana Isabel Torres‐Suárez is an author at Universidad Complutense de Madrid specializing in medicine, pharmacology, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	660
2	Engineering	8	8	360
3	Natural Sciences	4	4	75
4	Biochemistry	3	3	60
5	Health Sciences	1	1	15

Ana Isabel Torres‐Suárez

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Cannabidiol reduces ethanol consumption, motivation and relapse in mice Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Carmen M. Navarrón, Addiction Biology	2017	145
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy Dolores Hernán Pérez de la Ossa, Alessia Ligresti, María Esther Gil-Alegre, Journal of Controlled Release Cannabis UseNanomedicineEngineeringPolymer-drug ConjugateMedicine	2012	111
CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer Ana Isabel Fraguas‐Sánchez, Ana Fernández-Carballido, Rebeca Simancas-Herbada, International Journal of Pharmaceutics NanomedicineDoxorubicin-based ChemotherapyPolymer-drug ConjugateMedicinePharmacology	2019	103
Local Delivery of Cannabinoid-Loaded Microparticles Inhibits Tumor Growth in a Murine Xenograft Model of Glioblastoma Multiforme Dolores Hernán Pérez de la Ossa, Mar Lorente, María Esther Gil-Alegre, PLoS ONE	2013	100
PLGA Nanoparticles for the Intraperitoneal Administration of CBD in the Treatment of Ovarian Cancer: In Vitro and In Ovo Assessment Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez, Marie Cohen, Pharmaceutics	2020	88
Stability characteristics of cannabidiol for the design of pharmacological, biochemical and pharmaceutical studies Ana Isabel Fraguas‐Sánchez, Ana Fernández-Carballido, Cristina Martín‐Sabroso, Journal of Chromatography B Pharmaceutical SciencePharmaceutical ChemistryPharmacological StudyMedicineStability Characteristics	2020	81
Lipid nanocapsules decorated and loaded with cannabidiol as targeted prolonged release carriers for glioma therapy: In vitro screening of critical parameters Juan Aparicio-Blanco, Víctor Sebastián, Jean‐Pierre Benoît, European Journal of Pharmaceutics and Biopharmaceutics NanoparticlesNanomedicineNeuro-oncologyGlioma TherapyEngineering	2018	78
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Ana Isabel Fraguas‐Sánchez, British Journal of Pharmacology	2018	61
Cannabidiol Enhances the Passage of Lipid Nanocapsules across the Blood–Brain Barrier Both in Vitro and in Vivo Juan Aparicio-Blanco, Ignacio A. Romero, David Male, Molecular Pharmaceutics NanoparticlesNanotherapeuticsEngineeringBiomedical EngineeringBrain Drug Delivery	2019	61
Vasodilator effects of visnagin in isolated rat vascular smooth muscle Juan Duarte, Francisco Pérez‐Vizcaíno, Ana Isabel Torres‐Suárez, European Journal of Pharmacology MedicineVascular PharmacologyPhysiologyBiomechanicsVascular Adaptation	1995	51

Page 1